We are live on
!
Find out more
Allianz Asset Management Portfolio holdings
AUM
$95.4B
1-Year Est. Return
38.74%
This Fund
S&P 500
This Quarter
Est. Return
+2.29%
1 Year Est. Return
+38.74%
3 Year Est. Return
+101.74%
5 Year Est. Return
+133.96%
10 Year Est. Return
+765.1%
AUM
$93.9B
AUM Growth
+$6.07B
(+6.9%)
Cap. Flow
-$722M
Cap. Flow
% of AUM
-0.77%
Top 10 Holdings %
Top 10 Hldgs %
10.12%
Holding
2,724
New
225
Increased
1,153
Reduced
856
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fluor
FLR
|
+$224M |
| 2 |
Entergy
ETR
|
+$194M |
| 3 |
General Dynamics
GD
|
+$190M |
| 4 |
Vanguard Real Estate ETF
VNQ
|
+$147M |
| 5 |
Alibaba
BABA
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$291M |
| 2 |
Valero Energy
VLO
|
+$197M |
| 3 |
Wells Fargo
WFC
|
+$196M |
| 4 |
Apple
AAPL
|
+$193M |
| 5 |
Macy's
M
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.35% |
| 2 | Financials | 10.69% |
| 3 | Healthcare | 9.92% |
| 4 | Industrials | 6.49% |
| 5 | Consumer Discretionary | 6.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
AMN Healthcare
AMN
$1.21B
| $13.9M | 0.01% |
347,414
-263,417
| -43% | -$9.74M |
|
977
EPAM Systems
EPAM
$4.99B
| $13.9M | 0.01% |
215,900
-8,377
| -4% | -$611K |
|
978
CALL
Citigroup
C
$226B
| $13.8M | 0.01% |
325,900
+243,800
| +297% | +$10.8M |
|
979
Paylocity
PCTY
$8.29B
| $13.8M | 0.01% |
319,029
-93,630
| -23% | -$3.51M |
|
980
PUT
Applied Materials
AMAT
$421B
| $13.8M | 0.01% |
574,600
+316,900
| +123% | +$6.99M |
|
|
SPR
981
DELISTED
Spirit AeroSystems
SPR
| $13.7M | 0.01% |
318,330
+145,559
| +84% | +$6.7M |
|
982
Citizens Financial Group
CFG
$30.6B
| $13.6M | 0.01% |
682,610
-180,450
| -21% | -$4.01M |
|
983
O-I Glass
OI
$1.09B
| $13.5M | 0.01% |
+751,433
| New | +$13.8M |
|
984
PUT
Roper Technologies
ROP
$39B
| $13.5M | 0.01% |
79,200
+21,000
| +36% | +$3.67M |
|
985
PUT
Analog Devices
ADI
$186B
| $13.5M | 0.01% |
238,100
+104,300
| +78% | +$5.97M |
|
|
AVX
986
DELISTED
AVX Corporation
AVX
| $13.5M | 0.01% |
992,298
-189,902
| -16% | -$2.5M |
|
|
DI
987
DELISTED
PIMCO Diversified Income Active Exchange-Traded Fund
DI
| $13.5M | 0.01% |
275,000
| – | – |
|
|
POT
988
DELISTED
Potash Corp Of Saskatchewan
POT
| $13.4M | 0.01% |
830,793
+176,713
| +27% | +$2.96M |
|
989
The Ensign Group
ENSG
$10.6B
| $13.4M | 0.01% |
682,443
-303,797
| -31% | -$6.07M |
|
990
Neurocrine Biosciences
NBIX
$16.3B
| $13.3M | 0.01% |
293,176
-11,231
| -4% | -$517K |
|
|
DO
991
PUT
DELISTED
Diamond Offshore Drilling
DO
| $13.3M | 0.01% |
546,400
| – | – |
|
|
NSR
992
DELISTED
Neustar Inc
NSR
| $13.2M | 0.01% |
562,986
-43,703
| -7% | -$1.04M |
|
993
SFL Corp
SFL
$1.61B
| $13.2M | 0.01% |
895,328
+217,111
| +32% | +$3.23M |
|
994
PUT
Boston Scientific
BSX
$72B
| $13.2M | 0.01% |
564,100
+112,300
| +25% | +$2.43M |
|
995
Manhattan Associates
MANH
$11.1B
| $13.2M | 0.01% |
205,528
+172,087
| +515% | +$10.7M |
|
996
Howard Hughes
HHH
$4.06B
| $13.2M | 0.01% |
+120,936
| New | +$12.4M |
|
997
Acadia Healthcare
ACHC
$2.87B
| $13.2M | 0.01% |
237,387
-53,162
| -18% | -$3.11M |
|
998
CALL
Medtronic
MDT
$110B
| $13.1M | 0.01% |
151,500
+96,800
| +177% | +$7.83M |
|
999
Helix Energy Solutions
HLX
$1.47B
| $13.1M | 0.01% |
1,939,695
+1,347,429
| +228% | +$9.75M |
|
|
PPL
1000
PUT
PPL Corp
PPL
$26B
| $13.1M | 0.01% |
347,100
+139,000
| +67% | +$5.29M |
|
Similar funds
Allianz Asset Management's Q2 2016 Portfolio in Review
As of Q2 2016, Allianz Asset Management held 2,724 positions worth $93.9B, up 6.9% from $87.9B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Allianz Asset Management's Q2 2016 filing shows 225 new, 1,153 increased, 856 reduced and 182 closed positions. Its largest new stake was S&P Global: 874,259 shares worth $93.8M. The largest sale was Teva Pharmaceuticals, an estimated $291M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.
- Allianz Asset Management's largest Q2 2016 buy was S&P Global: 874,259 shares worth $93.8M.
- Allianz Asset Management added most to Fluor in Q2 2016, an estimated $224M increase.
- Allianz Asset Management's biggest Q2 2016 reduction was Teva Pharmaceuticals, cutting an estimated $291M.
- Allianz Asset Management fully exited ATMEL CORP in Q2 2016, selling an estimated $79.4M.
- Allianz Asset Management's ten largest holdings make up 10% of its $93.9B portfolio in Q2 2016.
- Allianz Asset Management opened 225 new positions and closed 182 in Q2 2016.
- Allianz Asset Management's portfolio value rose 6.9% quarter-over-quarter to $93.9B.
Based on Allianz Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.